---
title: Update on Candida Auris
description: Candida auris fungus is frequently a multidrug-resistant organism that causes serious, often deadly infections.  I first became aware of it about a year ago.
image: https://blog.cola.org/hubfs/Capture-17.png
---

ISO 9001:2015

- [Careers](http://www.cola.org/careers/) 
    - [A Great Place to Work](http://www.cola.org/careers/a-great-place-to-work/)
    - [Current Openings](http://www.cola.org/careers/current-openings/)
- [Press Room](http://www.cola.org/press-room/)
- Member Login 
    - [COLAcentral](https://www.colacentral.com)
    - [Board of Directors](http://board.cola.org/)
- visit related COLA sites 
    - [GiveBack365](http://www.GiveBack365.org)
    - [Lab Testing Matters](http://www.LabTestingMatters.org)
    - [MyConsultantCentral](http://www.myconsultantcentral.com/)
- 1-800-981-9883

![ColaUpdatedLogoStackedWhiteBackground-1](https://blog.cola.org/hs-fs/hubfs/ColaUpdatedLogoStackedWhiteBackground-1.png?width=306&height=111&name=ColaUpdatedLogoStackedWhiteBackground-1.png)

 

<https://www.facebook.com/COLAorg> <https://twitter.com/COLAAccredit> <https://www.linkedin.com/company/62607> <http://www.cola.org/feed/>

![ColaUpdatedLogoStackedWhiteBackground-1](https://blog.cola.org/hs-fs/hubfs/ColaUpdatedLogoStackedWhiteBackground-1.png?width=210&height=76&name=ColaUpdatedLogoStackedWhiteBackground-1.png)

 

ISO 9001:2015

- [Careers](http://www.cola.org/careers/) 
    - [A Great Place to Work](http://www.cola.org/careers/a-great-place-to-work/)
    - [Current Openings](http://www.cola.org/careers/current-openings/)
- [Press Room](http://www.cola.org/press-room/)
- Member Login 
    - [COLAcentral](https://www.colacentral.com)
    - [LabUniversity](https://cola.absorbtraining.com/default.aspx#/login)
    - [Board of Directors](http://board.cola.org/)
- visit related COLA sites 
    - [COLA Resources, Inc.](http://www.criedu.org/)
    - [GiveBack365](http://www.GiveBack365.org)
    - [Lab Testing Matters](http://www.LabTestingMatters.org)
    - [LabUniversity](http://www.labuniversity.org)
    - [MyConsultantCentral](http://www.myconsultantcentral.com/)

1-800-981-9883

<https://blog.cola.org/insider/lab-director-requirements-0-0-0-1-0-0-0-0-0-1-0-0-0-0-1-1-0-0-0-0-0-0-0#go>

<http://www.cola.org/feed/> <https://www.linkedin.com/company/62607> <https://twitter.com/COLAAccredit> <https://www.facebook.com/COLAorg>

[![2021_newest_logo_cola-footer (1)](https://blog.cola.org/hs-fs/hubfs/2021_newest_logo_cola-footer%20(1).png?width=261&name=2021_newest_logo_cola-footer%20(1).png)](http://www.cola.org/)

- [About COLA Inc.](http://www.cola.org/cola-clia-certification-accreditation-application/) 
    - [Overview](http://www.cola.org/lab-testing-accreditation-quality/) 
          - [History Mission and Values](http://www.cola.org/cola-clia-certification-accreditation-application/)
          - [Joint Commission Affiliated Labs](http://www.cola.org/lab-testing-accreditation-quality/joint-commission-affiliated-labs/)
          - [California](http://www.cola.org/lab-testing-accreditation-quality/cola-accreditation-in-california/)
    - [Board of Directors](http://www.cola.org/cola-clia-certification-accreditation-application/board-of-directors/)
    - [Executive Team](http://www.cola.org/cola-clia-certification-accreditation-application/executives-of-cola/)
    - [News Releases](http://www.cola.org/cola-news/)
    - Additional COLA Sites 
          - [GiveBack 365](http://www.cola.org/giveback-365/)
          - [Lab Testing Matters](https://www.cola.org/lab-testing-matters/)
          - [Near Patient Testing Matters](https://www.cola.org/near-patient-testing-matters/)
          - [MyConsultantCentral](https://www.cola.org/myconsultantcentral/)
    - [Our ISO Certification](http://www.cola.org/lab-testing-accreditation-quality/iso-certification-quality-control/)
    - [Apply for COLA](http://www.cola.org/lab-testing-accreditation-quality/clia-application-clia-accreditation/)
- Quality Accreditation Services 
    - [Accreditation - Clinical Laboratory](http://www.cola.org/lab-testing-accreditation-quality/what-is-cola/)
    - [Mobile Laboratory Accreditation for EMS](https://education.cola.org/mobile-laboratory-accreditation)
    - Laboratory Experts 
          - [Surveyors](http://www.cola.org/cola-clia-certification-accreditation-application/cola-surveyors/)
    - [CDC LOCS Updates](https://blog.cola.org/updates)
    - [Insider Blog](https://blog.cola.org/blog)
    - Additional Resources 
          - [Patient Safety Program](https://www.cola.org/patient-safety/)
          - [HIPAA Information](https://www.cola.org/hipaa-information/)
          - [Lab Tests Online](https://www.cola.org/lab-tests-online/)
    - [Apply for COLA](http://www.cola.org/lab-testing-accreditation-quality/clia-application-clia-accreditation/)
- Training & Development 
    - [Individualized Quality Control Plan](https://education.cola.org/individualized-quality-control-plan-course)
    - Laboratory Enrichment Forum 
          - [Attendees](https://education.cola.org/2023-laboratory-enrichment-forum)
          - [Sponsors](https://education.cola.org/en-us/2023-sponsor)
    - [Laboratory Director Course](https://www.cola.org/laboratory-director-course/)
    - [Waived Testing Toolkit](https://education.cola.org/colas-waived-testing-toolkit)
    - [Lab Link](https://www.cola.org/lab-link/)
    - [COLA Primers/Ebooks](https://www.cola.org/education-resources/cola-primers-ebooks/)
    - [COLA's Insights](http://www.cola.org/education-resources/laboratory-education/)
    - [Webinars](http://www.cola.org/webinars/)
- [Workforce Action Alliance](https://education.cola.org/2023-workforce-action-alliance)
- FDA Services 
    - [Third Party Review](http://www.cola.org/third-party-review/)
- [Contact Us](https://education.cola.org/contact-us-page)

# Update on Candida Auris

- [Home](http://www.cola.org/)
- Update on Candida Auris

[May 07, 2019](https://blog.cola.org/insider/archive/2019/05/07) [News](https://blog.cola.org/insider/topic/news) [clinical laboratory](https://blog.cola.org/insider/topic/clinical-laboratory) [Dr. John Daly](https://blog.cola.org/insider/author/dr-john-daly)

<https://blog.cola.org/insider/lab-director-requirements-0-0-0-1-0-0-0-0-0-1-0-0-0-0-1-1-0-0-0-0-0-0> <https://blog.cola.org/insider/lab-director-requirements-0-0-0-1-0-0-0-0-0-1-0-0-0-0-1-1-0-0-0-0-0-0-0-0>

[![](https://blog.cola.org/hubfs/Capture-17.png)](https://blog.cola.org/insider/lab-director-requirements-0-0-0-1-0-0-0-0-0-1-0-0-0-0-1-1-0-0-0-0-0-0-0)

- [Tweet](https://twitter.com/share)

Candida auris fungus is frequently a multidrug-resistant organism that causes serious, often deadly infections.  I first became aware of it about a year ago and published information on the website labtestingmatters.org.  C. auris was originally identified in Japan in 2009 and subsequently became identified in more than 20 countries around the globe including the United States. 

 

---

---

A year ago I indicated that approximately 150 infections had been identified in the US, predominantly in hospitals and nursing homes.  Today that number is greater than 600 US infections with greater than 300 identified in New York State and the majority of those cases in approximately 50% of the hospitals in New York City.  There are several major considerations you should keep in mind about C. auris:   

1. C. auris can cause sepsis and other types of invasive infections. The infections are most common in patients with multiple medical problems who are hospitalized or residing nursing homes.  The mortality rate can reach as high as 60%.
2. C. auris can be difficult to identify and misidentification may lead to inappropriate management. Unrecognized, C. auris can lead to spread of infection to other patients in a given facility. The most reliable way to identify C. auris is matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS).  Some molecular methods will also accurately identify the organism.  In instances where these technologies are not available for Candida speciation, the State Health Department or CDC need to be contacted to provide assistance.
3. As it can cause significant outbreaks in health care settings, identification and microbial resistance determination must be performed rapidly so that appropriate isolation procedures can be instituted to avert the nosocomial spread of infection.
4. The majority of infections respond to the class of antifungal medications known as echinocandins, but some strains resist all three main classes of drugs used to treat Candida infection.
5. C. auris can cause colonization of surfaces for a period of weeks to months and can be quite difficult to eradicate. Some patients and care givers have been documented to have skin colonization for over a year.  It rapidly and readily colonizes infected patient rooms.  It has been identified on surfaces of all types from windowsills to patient care machines to care deliverer shoes even after the patient is gone and the room and staff have received decontamination.  In a London hospital, 70 patients were infected with the organism believed to have been spread by hospital thermometers.  Bleach works well to eradicate the organism, but obviously, this cannot be used on every surface and instrument.  FDA approved and CDC recommended disinfectants are available to assist in the prevention of contamination and subsequent nosocomial infection.

I bring this topic to the fore again because Candida is a not uncommon blood stream infection and it is important to rapidly speciate the Candida when it is identified.  Because many facilities lack the ability to speciate Candida auris, it is essential to reach out to your state public health laboratory for assistance to assure expeditious Candida species identity and prevent Candida auris from becoming a major nosocomial problem throughout your facility and ultimately the country.

*Also, don't forget to stay connected and join our [Quality Lab Group](https://www.linkedin.com/groups/12067669?utm_campaign=E-Newsletters&utm_source=hs_email&utm_medium=email&utm_content=2&_hsenc=p2ANqtz-8fnN3G8A11fmX7PhJNxW_Wtfi3CDDVARgIRfAs8HwAr6ydFt7YraMnW2InLvTIwRI9QTU1v2P88WiYX_Ei0mg6CGcKIQ&_hsmi=2) on LinkedIn!*

 

[News](https://blog.cola.org/insider/topic/news), [clinical laboratory](https://blog.cola.org/insider/topic/clinical-laboratory)

### Related posts

<https://blog.cola.org/insider/fda-warning-potential-false-negative-cardiac-tests-0>

[The Next Big Thing in Diagnosis of Ebola](https://blog.cola.org/insider/fda-warning-potential-false-negative-cardiac-tests-0) December 04, 2019

<https://blog.cola.org/insider/the-continued-rise-in-cost-of-healthcare>

[The Continued Rise in Cost of Healthcare](https://blog.cola.org/insider/the-continued-rise-in-cost-of-healthcare) February 06, 2020

<https://blog.cola.org/insider/the-a-to-z-of-testing-for-folate-deficiency>

[The A to Z of Testing for Folate Deficiency](https://blog.cola.org/insider/the-a-to-z-of-testing-for-folate-deficiency) January 16, 2020

<https://blog.cola.org/insider/scarlet-fever-the-comeback-kid>

[Scarlet Fever: The Comeback Kid](https://blog.cola.org/insider/scarlet-fever-the-comeback-kid) October 31, 2019

<https://blog.cola.org/insider/fda-warning-potential-false-negative-cardiac-tests>

[FDA Warning: Potential False Negative Cardiac Tests](https://blog.cola.org/insider/fda-warning-potential-false-negative-cardiac-tests) November 14, 2019

<https://blog.cola.org/insider/declining-reimbursement-in-the-clinical-laboratory>

[Declining Reimbursement in the Clinical Laboratory](https://blog.cola.org/insider/declining-reimbursement-in-the-clinical-laboratory) January 30, 2020

About the author

### Dr. John Daly

![](https://blog.cola.org/hubfs/John%20Daly%20-%20COLA_Headshot37.jpg)

John T. Daly, M.D. received his MD degree at Weill Cornell University Medical College, performed his internship and residency in Anatomic and Clinical pathology at Duke University Medical Center and a residency in Forensic Pathology at the Office of the Chief Medical Examiner in Chapel Hill, N.C. He is board certified in anatomic, clinical and forensic pathology. Through the course of his career, Dr. Daly has had extensive experience directing and advising laboratories of all sizes including physician office practices, Federal Health Clinics, surgical centers, Community Hospitals and the integrated academic health system clinical laboratories of Duke Medicine. He retired as Director of Laboratories of Duke Medicine, and continues his affiliation as a member of the emeritus staff.

 Advertisement

- <https://blog.cola.org/insider/the-continued-rise-in-cost-of-healthcare>
  
  [The Continued Rise in Cost of Healthcare](https://blog.cola.org/insider/the-continued-rise-in-cost-of-healthcare) February 06, 2020
- <https://blog.cola.org/insider/declining-reimbursement-in-the-clinical-laboratory>
  
  [Declining Reimbursement in the Clinical Laboratory](https://blog.cola.org/insider/declining-reimbursement-in-the-clinical-laboratory) January 30, 2020
- <https://blog.cola.org/insider/the-a-to-z-of-testing-for-folate-deficiency>
  
  [The A to Z of Testing for Folate Deficiency](https://blog.cola.org/insider/the-a-to-z-of-testing-for-folate-deficiency) January 16, 2020
- <https://blog.cola.org/insider/fda-warning-potential-false-negative-cardiac-tests-0>
  
  [The Next Big Thing in Diagnosis of Ebola](https://blog.cola.org/insider/fda-warning-potential-false-negative-cardiac-tests-0) December 04, 2019
- <https://blog.cola.org/insider/fda-warning-potential-false-negative-cardiac-tests>
  
  [FDA Warning: Potential False Negative Cardiac Tests](https://blog.cola.org/insider/fda-warning-potential-false-negative-cardiac-tests) November 14, 2019

 Advertisement

### Posts by Tag

- [accurate test results (20)](https://blog.cola.org/insider/tag/accurate-test-results)
- [bitcoin (1)](https://blog.cola.org/insider/tag/bitcoin)
- [cancer (1)](https://blog.cola.org/insider/tag/cancer)
- [clia (1)](https://blog.cola.org/insider/tag/clia)
- [clia 1988 regulations (1)](https://blog.cola.org/insider/tag/clia-1988-regulations)
- [clia accreditation (1)](https://blog.cola.org/insider/tag/clia-accreditation)
- [clia guidelines (1)](https://blog.cola.org/insider/tag/clia-guidelines)
- [clia regulations (1)](https://blog.cola.org/insider/tag/clia-regulations)
- [clinical laboratory (57)](https://blog.cola.org/insider/tag/clinical-laboratory)
- [cms clia (1)](https://blog.cola.org/insider/tag/cms-clia)
- [colon (1)](https://blog.cola.org/insider/tag/colon)
- [cost effective lab management (2)](https://blog.cola.org/insider/tag/cost-effective-lab-management)
- [health care costs (1)](https://blog.cola.org/insider/tag/health-care-costs)
- [health care trends (2)](https://blog.cola.org/insider/tag/health-care-trends)
- [healthcare finance (1)](https://blog.cola.org/insider/tag/healthcare-finance)
- [lab equipment (1)](https://blog.cola.org/insider/tag/lab-equipment)
- [lab test (5)](https://blog.cola.org/insider/tag/lab-test)
- [lab test utilization (7)](https://blog.cola.org/insider/tag/lab-test-utilization)
- [lab tests (7)](https://blog.cola.org/insider/tag/lab-tests)
- [lab utilization (2)](https://blog.cola.org/insider/tag/lab-utilization)
- [Laboratory Management (9)](https://blog.cola.org/insider/tag/laboratory-management)
- [laboratory medicine (23)](https://blog.cola.org/insider/tag/laboratory-medicine)
- [Laboratory Operations (10)](https://blog.cola.org/insider/tag/laboratory-operations)
- [laboratory test utiliazation (3)](https://blog.cola.org/insider/tag/laboratory-test-utiliazation)
- [News (56)](https://blog.cola.org/insider/tag/news)
- [patient outcomes (1)](https://blog.cola.org/insider/tag/patient-outcomes)
- [patient satisfaction (1)](https://blog.cola.org/insider/tag/patient-satisfaction)
- [Personnel Competence (1)](https://blog.cola.org/insider/tag/personnel-competence)
- [reference laboratory (1)](https://blog.cola.org/insider/tag/reference-laboratory)
- [test utilization (2)](https://blog.cola.org/insider/tag/test-utilization)

See all

  

Search Blog:

[Careers](http://www.cola.org/careers/) | [Press Room](http://www.cola.org/press-room/)

![ColaUpdatedLogoStackedWhiteBackground-1](https://blog.cola.org/hs-fs/hubfs/ColaUpdatedLogoStackedWhiteBackground-1.png?width=175&height=64&name=ColaUpdatedLogoStackedWhiteBackground-1.png)

9881 Broken Land Pkwy Suite 200 | Columbia, MD 21046-3016  
Phone (800) 981-9883 | Fax (410) 381-8611 | Email [info@cola.org](mailto:info@cola.org)

[Privacy Policy](http://www.cola.org/privacy-policy/) | [Terms Of Service](http://www.cola.org/terms-of-service/) | [Interested In Advertising?](https://education.cola.org/cola-adnetwork)

- follow us:
- <https://www.facebook.com/ColaInc/>
- <https://twitter.com/Cola_Inc>
- <https://www.linkedin.com/company/cola/>
- <http://www.cola.org/feed/>

 Visit:   
[Near Patient Testing Matters](http://www.nearpatienttestingmatters.org/)  
[Lab Testing Matters](http://www.labtestingmatters.org/)  
[My Consultant Central](http://www.myconsultantcentral.com/)

 Member Login:   
[COLAcentral](https://www.colacentral.com)  
[Board of Directors](http://board.cola.org/)

site development by [![](https://blog.cola.org/hubfs/COLA-Jun2017/images/NL_bug.png)](http://www.nextlogik.com)

© 2004 - 2017 COLA All Rights Reserved

![](https://dc.ads.linkedin.com/collect/?pid=169932&fmt=gif)